XBiotech

XBIT NASDAQ
7.15
+0.16
+2.29%
盘后: 7.15 0 0.00% 16:00 06/14 EDT
开盘
7.24
昨收
6.99
最高
7.24
最低
6.92
成交量
17.24万
成交均量(3M)
15.52万
52周最高
11.74
52周最低
2.130
换手率
0.42%
市值
2.93亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供XBiotech XBIT股票价格,XBiotech股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

XBiotech Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. It focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The Company has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The Company has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. It also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS).
展开 >

最近浏览

名称
价格
涨跌幅